CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Oct. 01, 2021
Statement of Cash Flows [Abstract]
Net income	$ 26,810	$ 76,799
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other impairment charges	167,453	197,641
Stock-based compensation expense	27,799	26,235
Non-cash interest expense	3,021	3,757
Unrealized (gain) loss on investment in ESAB Corporation	(72,412)	0
Realized gain on cost basis investment	(8,800)	0
Debt extinguishment charges	20,104	29,870
Deferred income tax expense (benefit)	(3,458)	(5,904)
(Gain)/Loss on sale of property, plant and equipment	352	(1,483)
Changes in operating assets and liabilities:
Trade receivables, net	(43,315)	(70,407)
Inventories, net	(119,145)	(130,348)
Accounts payable	34,147	143,694
Other operating assets and liabilities	(52,459)	(9,971)
Net cash (used in) provided by operating activities	(19,903)	259,883
Cash flows from investing activities:
Purchases of property, plant and equipment and intangibles	(68,668)	(73,595)
Proceeds from sale of property, plant and equipment	2,746	2,908
Acquisitions, net of cash received, and investments	(73,390)	(222,961)
Net cash used in investing activities	(139,312)	(293,648)
Cash flows from financing activities:
Proceeds from borrowings on term credit facility	450,000	515,696
Payments under term credit facility	(785,000)	0
Repayments of borrowings on revolving credit facilities and other	(608,877)	(409,961)
Repayments of borrowings on Senior notes	(300,000)	(700,000)
Repayments of borrowings on Euro senior notes	(386,278)	0
Distribution from ESAB Corporation, net	1,143,369	0
Payment of debt issuance costs	(2,938)	0
Proceeds from issuance of common stock, net	2,530	738,177
Payment of debt extinguishment costs	(12,704)	(24,375)
Deferred consideration payments and other	(6,857)	(7,700)
Net cash (used in) provided by financing activities	(506,755)	111,837
Effect of foreign exchange rates on Cash and cash equivalents and Restricted Cash	1,557	(1,659)
(Decrease) increase in Cash and cash equivalents and Restricted cash	(664,413)	76,413
Cash and cash equivalents and Restricted Cash, beginning of period	719,370	101,069
Cash and cash equivalents, end of period	54,957	177,482
Supplemental Cash Flow Information [Abstract]
Common stock issued for acquisition, net of issuance costs	$ 0	$ 285,681